Searched for
ANTIBODY BASED THERAPY
Avammune’s big bet: Why the future of cancer treatment may come in a pillAs global oncology races toward next-generation therapies, Avammune Therapeutics is betting on affordable, orally administered immunotherap...- Japanese biotech developing tooth-regrowing drug raises $5.3 million to advance human trialsToregem BioPharma has secured $5.3 million to advance its experimental tooth-regeneration drug, TRG035, into Phase II clinical trials. The ...
- Chinese medicines bring relief to India’s cancer patientsIndia’s cancer treatment landscape is seeing a shift as lower-cost immunotherapy drugs developed in China and marketed through Indian partn...
- Tooth regeneration therapy enters first human clinical trials in JapanA groundbreaking human trial in Japan is exploring a revolutionary treatment to regrow teeth. Researchers have identified a way to activate...
- US FDA approves J&J's blood cancer therapyJohnson & Johnson said on Thursday the U.S. Food and Drug Administration had approved its antibody-based therapy for patients with a diffic...
- GSK-Vir therapy works against Omicron sub-variant, data suggestsBased on pseudovirus and extensive pharmacokinetic data, the company said it believed the 500 mg dose of sotrovimab is sufficient to retain...
- AstraZeneca files for US approval of drug to prevent COVID-19The treatment, an antibody therapy called AZD7442, had reduced the risk of people developing any COVID-19 symptoms by 77% in a late-stage t...
- Covid antibody that protects against broad range of variants identifiedThe new antibody attaches to a part of the virus that differs little across the variants, meaning that it is unlikely for resistance to ari...
- Biocon Biologics gets licence from Adagio Therapeutics for antibody treatment of COVID-19"ADG20, a novel monoclonal antibody targeting the spike protein of SARS-CoV-2 and related coronaviruses, is in global clinical development ...
- Zydus Cadila, first Indian Company gets permission for clinical trials of antibodies cocktail to treat COVID-19: SourcesThe only Indian company Zydus Cadila which claims to have developed neutralising monoclonal antibodies (mAbs)-based cocktail for the treatm...
- 65 yr old man becomes 1st Covid patient to get antibody cocktail at Apollo in DelhiAs part of this single dose infusion-based treatment, patients with mild to moderate symptoms, are offered a cocktail of Casirivimab and Im...
- Fortis hospital in Delhi offers monoclonal antibody therapy; awaits takersAs part of this single dose infusion-based treatment, patients with mild to moderate symptoms are offered a cocktail of Casirivimab and Imd...
- Coronavirus variants from Brazil, South Africa are less susceptible to antibodies, says study"This is worrisome because the rapid spread of variants that might not be efficiently inhibited by antibodies could undermine our current v...
- Indiscriminate use of convalescent plasma therapy in COVID patients not advisable: ICMRIn an "Evidence Based Advisory to address Inappropriate Use of Convalescent Plasma in COVID-19 Patients", the Indian Council of Medical Res...
- ICMR readies to conduct clinical trials of animal-derived antibodiesAntibodies from animals have been used to control many viral and bacterial infections such as rabies, hepatitis B, vaccine virus, tetanus, ...
- ICMR, Biological E develop purified equine antiserumThe therapy works like plasma therapy. However, the blood plasma is obtained from animals — from horses, in this case — that have recovered...
- What are antibody therapies and who is developing them for COVID-19?More recently, scientists have developed treatments called monoclonal antibodies -- antibodies that can be isolated and manufactured in lar...
- Looking at 'repurposing' drugs: BioconWe are working to repurpose our novel monoclonal antibody Itolizumab (used in psoriasis) to treat complications caused by Covid-19 infectio...
- ICMR to fund research in ‘immunology’ cureThe ICMR has asked research institutions including hospitals to participate in the funding round and it expects research activities to take...
- Covid-19: Kerala institute ready for plasma trials, but has no patients to testThe Thiruvananthapuram-based institute, which is an institute of national importance under the Department of Science and Technology, receiv...
Load More
